Marker Therapeutics Inc (MRKR)

[Bio7mm]

I don't think most people understand the science that Glynn Wilson is trying to describe in these releases. It is very technical and takes some imagination and vision to truly see how TapImmume could revolutionize vaccines. He also needs to build awareness on Walll Street because the share price was so crazy low for years that it went under the radar for most institutional investors. But now we start the uptrend that will last for 20 years as they create many first in class, superior treatments for hard to treat diseases. A wealth creation machine is being built before our eyes.